So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry’s latest cancer awareness campaigns. More: Lilly encourages women to 'take health into their own hands' with new breast cancer awareness ad Source:
read moreThe FDA earlier this month issued separate warning letters to Chinese drug ingredient firms Nuowei Chemistry and Innovation Pharmaceutical. The write-ups cover the quality control and testing shortfalls that led to both companies receiving U.S. import bans in late January.
read more
New immunotherapy offers hope for recurrent cervical cancer More: Libtayo available in Scotland for cervical cancer patients Source: News
read more
Treatment expands options for HER2-negative metastatic breast cancer More: Lynparza approved in Scotland for BRCA-mutated breast cancer patients Source: News
read moreSome two years into Leqembi’s launch, Eisai continues to go all-in on its Alzheimer’s disease-fighting antibody, which the company believes could be finally nearing a “growth expansion phase” despite slow sales so far in the U.S. More: Eisai execs flag
read moreDuring its quarterly earnings presentation, Vertex said that it expects to begin shipping newly approved non-opioid pain reliever Journavx by the end of this month and is working to secure “broad stocking agreements” with national and regional pharmacy chains. More:
read more© 1994 - 2025 B.M. Pharmaceuticals